Clinical Trial Update: Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3 [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Bricanyl Turbuhaler M2 and M3 at 0.5 mg and 1.5 mg in asthma to evaluate switching from M2 to M3; the study is completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Bricanyl Turbuhaler M2 (terbutaline)
• Bricanyl Turbuhaler M3 (terbutaline)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2016-11-07